A randomised comparative study evaluating the efficacy and tolerability of injection Diclofenac sodium 75mg/1ml given intradeltoid with injection Diclofenac sodium 75mg/3ml given intragluteal in the management of post operative pain.

Troikaa Pharmaceuticals Limited0 个研究点目标入组 250 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Patients in the age group of 18-65 years
•2.Patients of both sexes
•3.Patients with healthy deltoid/ gluteal muscle mass
•4.Patients undergoing operative procedures requiring hospitalization for at least 48 hours with moderate to severe pain
•5.Patients with moderate to severe pain at baseline (VAS 4 -10)

•1.Patients below 18 years and above 65 years of age
•2.OPD patients/ patients requiring hospitalization less than 48 hours
•3.Patients with compromised renal function
•4.Pregnant and lactating women
•5.Patients with history of bronchial asthma, peptic ulceration, bronchitis
•6.Patients with bleeding disorders
•7.Mentally retarded patients
•8.Unwilling patients
•9.Patients with known hypersensitivity to diclofenac sodium any other NSAIDs or any component of either of the study formulations
•10.Patients with mild baseline pain (1-3)

发起方